COSMOS Pharmaceutical Future Growth
Future criteria checks 1/6
COSMOS Pharmaceutical is forecast to grow earnings and revenue by 5.9% and 6.6% per annum respectively. EPS is expected to grow by 6.2% per annum. Return on equity is forecast to be 10.7% in 3 years.
Key information
5.9%
Earnings growth rate
6.2%
EPS growth rate
| Consumer Retailing earnings growth | 10.1% |
| Revenue growth rate | 6.6% |
| Future return on equity | 10.7% |
| Analyst coverage | Good |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 5/31/2027 | 1,208,961 | 30,781 | 16,450 | N/A | 12 |
| 5/31/2026 | 1,123,971 | 28,703 | 5,454 | N/A | 13 |
| 5/31/2025 | 1,039,241 | 26,882 | 2,339 | N/A | 13 |
| 8/31/2024 | 985,177 | 26,089 | N/A | N/A | N/A |
| 5/31/2024 | 964,989 | 24,454 | -635 | 55,175 | N/A |
| 2/29/2024 | 936,706 | 24,871 | N/A | N/A | N/A |
| 11/30/2023 | 900,111 | 24,085 | 681 | 54,534 | N/A |
| 8/31/2023 | 863,228 | 23,824 | N/A | N/A | N/A |
| 5/31/2023 | 827,697 | 23,797 | 7,798 | 54,434 | N/A |
| 2/28/2023 | 802,831 | 22,983 | N/A | N/A | N/A |
| 11/30/2022 | 788,292 | 23,209 | -3,655 | 41,973 | N/A |
| 8/31/2022 | 772,127 | 23,393 | N/A | N/A | N/A |
| 5/31/2022 | 755,414 | 23,155 | -11,303 | 32,194 | N/A |
| 2/28/2022 | 743,612 | 22,030 | N/A | N/A | N/A |
| 11/30/2021 | 733,387 | 25,329 | -5 | 35,596 | N/A |
| 8/31/2021 | 726,672 | 25,909 | N/A | N/A | N/A |
| 5/31/2021 | 726,424 | 27,156 | 1,811 | 27,875 | N/A |
| 2/28/2021 | 733,223 | 28,777 | N/A | N/A | N/A |
| 11/30/2020 | 723,309 | 25,736 | 28,882 | 50,935 | N/A |
| 8/31/2020 | 709,064 | 23,876 | N/A | N/A | N/A |
| 5/31/2020 | 684,403 | 21,435 | 39,513 | 65,461 | N/A |
| 2/29/2020 | 653,527 | 20,217 | N/A | N/A | N/A |
| 11/30/2019 | 638,034 | 18,951 | 10,653 | 38,209 | N/A |
| 8/31/2019 | 622,103 | 19,349 | N/A | N/A | N/A |
| 5/31/2019 | 611,137 | 19,185 | 5,339 | 34,379 | N/A |
| 2/28/2019 | 597,715 | 18,966 | N/A | N/A | N/A |
| 11/30/2018 | 585,536 | 18,857 | 1,302 | 30,947 | N/A |
| 8/31/2018 | 572,807 | 17,880 | N/A | N/A | N/A |
| 5/31/2018 | 557,999 | 17,633 | N/A | 32,586 | N/A |
| 2/28/2018 | 542,936 | 17,510 | N/A | N/A | N/A |
| 11/30/2017 | 526,523 | 17,313 | N/A | 35,488 | N/A |
| 8/31/2017 | 514,880 | 18,239 | N/A | N/A | N/A |
| 5/31/2017 | 502,732 | 18,215 | N/A | 36,938 | N/A |
| 2/28/2017 | 490,037 | 15,812 | N/A | N/A | N/A |
| 11/30/2016 | 477,739 | 14,981 | N/A | 34,300 | N/A |
| 8/31/2016 | 463,517 | 13,679 | N/A | N/A | N/A |
| 5/31/2016 | 447,273 | 12,435 | N/A | 30,986 | N/A |
| 2/29/2016 | 433,328 | 12,738 | N/A | N/A | N/A |
| 11/30/2015 | 423,817 | 12,474 | N/A | 22,426 | N/A |
| 8/31/2015 | 414,046 | 12,350 | N/A | N/A | N/A |
| 5/31/2015 | 408,466 | 11,694 | N/A | 19,454 | N/A |
| 2/28/2015 | 402,690 | 10,671 | N/A | N/A | N/A |
| 11/30/2014 | 392,527 | 10,286 | N/A | 26,260 | N/A |
| 8/31/2014 | 382,823 | 10,193 | N/A | N/A | N/A |
| 5/31/2014 | 371,825 | 10,600 | N/A | 25,962 | N/A |
| 2/28/2014 | 360,162 | 10,366 | N/A | N/A | N/A |
| 11/30/2013 | 349,966 | 9,975 | N/A | 17,627 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CSMY.F's forecast earnings growth (5.9% per year) is above the savings rate (2.6%).
Earnings vs Market: CSMY.F's earnings (5.9% per year) are forecast to grow slower than the US market (15.3% per year).
High Growth Earnings: CSMY.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: CSMY.F's revenue (6.6% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: CSMY.F's revenue (6.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CSMY.F's Return on Equity is forecast to be low in 3 years time (10.7%).